CN103356980A - Medicament for treating afterpains - Google Patents
Medicament for treating afterpains Download PDFInfo
- Publication number
- CN103356980A CN103356980A CN201310236037XA CN201310236037A CN103356980A CN 103356980 A CN103356980 A CN 103356980A CN 201310236037X A CN201310236037X A CN 201310236037XA CN 201310236037 A CN201310236037 A CN 201310236037A CN 103356980 A CN103356980 A CN 103356980A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- fructus
- herba
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating afterpains. The medicament is prepared from the following substances in parts by weight: hawthorn, cortex pseudolaricis, rhizoma acori graminei, ephedra, clove, saururus chinensis, chrysoidine, semen torreya, ramulus mori, scouring rush, herba eupatorii, rhizoma anemarrhenae, chinaroot greenbrier, milfoil, moutan bark, cynanchum glaucescens, root of kudzu vine, radix angelicae pubescentis, curcuma zedoary, selfheal, illicium verum, fructus viticis, jatamans valeriana rhizome, rhizoma curculiginis, folium artemisiae argyi, albizia flower, lonicerae flos, cortex acanthopanacis, quispualis indica, emblic leafflower fruit, Chinese olive, immature bitter orange, szechwan Chinaberry fruit, radices lithospermi, entada phaseoloides, pericarpium arecae, flos rosae rugosae, magnolia flower, Japanese polygala, radices sileris, rhizoma zingiberis, eclipta, folium turpiniae, aspongopus, edible tulip, morinda officinalis, pomegranate bark, semen pharbitidis, herba pyrolae, and marsdenia tenacissima. The medicament disclosed by the invention is available in materials, accurate in curative effect, high in effective rate by evidence of experiments, and low in cost.
Description
Technical field
The present invention relates to the department of obstetrics and gynecology field, relate in particular to a kind of medicine for the treatment of puerperal uterine contraction pain.
Background technology
Puerperal uterine contraction pain is one of modal clinical manifestation in puerperal, and the multipara is more than the primipara.The uterus is the contraction of tetanic property when pain, 1-2d occurs puerperal, and reflexive oxytocin secretion increases when continuing 2-3d Lock-out suckling, and pain is increased the weight of.The puerperal uterine contraction pain majority can be stood, and severe one can cause suffering to the puerpera, the difficult peace of sleeping and eating, and may produce unhealthy emotion, affect postpartum recovery, the harm baby's health.The Clinical Processing puerperal uterine contraction pain be mostly to inform the patient this for normal phenomenon, the suggestion patient restrains oneself, and use analgesic during serious uterine contraction pain, but analgesic has certain untoward reaction, can affect galactopoiesis.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of puerperal uterine contraction pain.
In order to realize purpose of the present invention, the invention provides a kind of medicine for the treatment of puerperal uterine contraction pain, it is to be made by the material of following weight parts: 50 parts of Fructus Crataegis, 50 parts of Cortex Pseudolariciss, 75 parts of Rhizoma Acori Graminei, 75 parts in Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, tangerine 13 parts, 30 parts of Semen Torreyaes, 5 parts of Ramulus Moris, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts of Rhizoma Smilacis Chinensiss, 75 parts of achillea millefoliums, 50 parts of Cortex Moutans, 15 parts of Rhizoma Cynanchi Stauntoniis, 75 parts of Radix Puerariaes, 50 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Fructus Anisi Stellatis, 30 parts of Fructus Viticises, 75 parts of Rhizoma valerianae latifoliaes, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Flos Lonicerae, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Canariis, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Fructus Toosendans, 5 parts of 50 parts of Semen Entadae of Radix Arnebiae (Radix Lithospermi), 50 parts of Pericarpium Arecae, 50 parts of Flos Rosae Rugosaes, 75 parts of Flos Magnoliaes, 50 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 50 parts of Herba Ecliptaes, 45 parts of leaf of Turpinia pomifera (Roxb) D O., 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
Preferably, medicine of the present invention can be made tablet, dispersible tablet, decoction or powder.
Raw material of the present invention is easy to get, determined curative effect, and high through the evidence effective percentage, cost is low.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Fructus Crataegi 50 grams, Cortex Pseudolaricis 50 grams, Rhizoma Acori Graminei 75 grams, Herba Ephedrae 75 grams, Flos Caryophylli 8 grams, Rhizoma Saururi (Herba Saururi) 25 grams, tangerine 13 grams, Semen Torreyae 30 grams, Ramulus Mori 5 grams, Herba Equiseti Hiemalis's 25 grams, Herba Eupatorii 15 grams, the Rhizoma Anemarrhenae 25 grams, Rhizoma Smilacis Chinensis 40 grams, achillea millefolium 75 grams, Cortex Moutan 50 grams, Rhizoma Cynanchi Stauntonii 15 grams, Radix Puerariae 75 grams, Radix Angelicae Pubescentis 50 grams, Rhizoma Curcumae 15 grams, Spica Prunellae 30 grams, Fructus Anisi Stellati 15 grams, Fructus Viticis 30 grams, Rhizoma valerianae latifoliae 75 grams, Rhizoma Curculiginis 15 grams, Folium Artemisiae Argyi 35 grams, Flos Albiziae 25 grams, Flos Lonicerae 25 grams, Cortex Acanthopancis 26 grams, Fructus Quisqualis 15 grams, Fructus Phyllanthi 25 grams, Fructus Canarii 30 grams, Fructus Aurantii Immaturus 15 grams, Fructus Toosendan 30 grams, Radix Arnebiae (Radix Lithospermi) 50 gram Semen Entadae 5 grams, Pericarpium Arecae 50 grams, Flos Rosae Rugosae 50 grams, Flos Magnoliae 75 grams, Herba Polygalae Japonicae 50 grams, Radix Saposhnikoviae 25 grams, Rhizoma Zingiberis 25 grams, Herba Ecliptae 50 grams, leaf of Turpinia pomifera (Roxb) D O. 45 grams, Aspongopus 60 grams, Pseudobulbus Cremastrae Seu Pleiones 50 grams, Radix Morindae Officinalis 50 grams, Pericarpium Granati 70 grams, Semen Pharbitidis 40 grams, Herba Pyrolae 35 grams and Caulis Marsdeniae Tenacissimae 50 grams, add 4500 milliliters of entry, heating is 5 hours under the condition of reflux, filters.Filtrate is concentrated into 1000 milliliters, is cooled to room temperature, be decoction of the present invention.
Experimental example
Puerperal uterine contraction pain be the hypogastric region paroxysmal that earlier stage of childbed causes because of uterine contraction have an intense pain puerperal uterotonic mouthful be to help uterine hemostasis, and the clot of intrauterine remnants is discharged, to promote the recovery in uterus.Uterine contraction and endogenic oxytocin, prostaglandin, slow to swash the many factors such as skin, 5-hydroxy tryptamine, leukotriene relevant, and what play a major role is oxytocin.Puerperal, the physiological change of uterine retraction was the multiple and inner membrance regeneration of body of uterus fiber contracting.The contracting of body of uterus fiber is that the myocyte dwindles again, show as myocyte's matter protein and decompose discharge, kytoplasm reduces, so the body of uterus contracting is tetanic property when multiple, the contraction of tetanic temper palace causes local organization ischemia, anoxia and nervous tissue's pressurized and violent paroxysmal pain occurs, this pain is spastic, mostly occurs in multipara, multiple birth, fetus is excessive or the puerpera of polyhydramnios.Make to reflexive strength of uterine contraction strengthen causing that pain increases the weight of during because of postpartum breastfeeding, puerpera even resistance are neonatal nursing.
1.1 physical data
Select multipara's 60 examples of vaginal delivery, smooth during product, without obstetrics' complication, puerperal uterine contraction pain, hurt like hell all appear puerperal.
Treat with the decoction that makes among the embodiment 1, wherein one day 2 times, each oral 100ml treated 3 days.Inactive other drug during the treatment.
Curative effect judging standard
Adopt WHO Pain Grading method, puerperal uterine contraction pain is divided into level Four.0 grade: painless; The I level: mild pain, be intermittence, can not medication; The II level: moderate pain, be lasting pain, not medication can not alleviating pain; The III level: serious pain, for continuing the variations such as violent pain, companion's blood pressure, pulse.Observe puerperal 24,48,72h uterine contraction pain situation.Following table as a result.
Claims (2)
1. a medicine for the treatment of puerperal uterine contraction pain is characterized in that it is to be made by the material of following weight parts: 50 parts of Fructus Crataegis, 50 parts of Cortex Pseudolariciss, 75 parts of Rhizoma Acori Graminei, 75 parts in Herba Ephedrae, 8 parts of Flos Caryophyllis, 25 parts of Rhizoma Saururi (Herba Saururi)s, tangerine 13 parts, 30 parts of Semen Torreyaes, 5 parts of Ramulus Moris, 25 parts of Herba Equiseties Hiemalis, 15 parts of Herba Eupatoriis, 25 parts of the Rhizoma Anemarrhenaes, 40 parts of Rhizoma Smilacis Chinensiss, 75 parts of achillea millefoliums, 50 parts of Cortex Moutans, 15 parts of Rhizoma Cynanchi Stauntoniis, 75 parts of Radix Puerariaes, 50 parts of Radix Angelicae Pubescentiss, 15 parts of Rhizoma Curcumae, 30 parts of Spica Prunellaes, 15 parts of Fructus Anisi Stellatis, 30 parts of Fructus Viticises, 75 parts of Rhizoma valerianae latifoliaes, 15 parts of Rhizoma Curculiginises, 35 parts of Folium Artemisiae Argyis, 25 parts of Flos Albiziaes, 25 parts of Flos Lonicerae, 26 parts of Cortex Acanthopanciss, 15 parts of Fructus Quisqualis, 25 parts of Fructus Phyllanthis, 30 parts of Fructus Canariis, 15 parts of Fructus Aurantii Immaturuss, 30 parts of Fructus Toosendans, 5 parts of 50 parts of Semen Entadae of Radix Arnebiae (Radix Lithospermi), 50 parts of Pericarpium Arecae, 50 parts of Flos Rosae Rugosaes, 75 parts of Flos Magnoliaes, 50 parts of Herba Polygalae Japonicae, 25 parts of Radix Saposhnikoviaes, 25 parts of Rhizoma Zingiberiss, 50 parts of Herba Ecliptaes, 45 parts of leaf of Turpinia pomifera (Roxb) D O., 60 parts of Aspongopuss, 50 parts of Pseudobulbus Cremastrae Seu Pleioness, 50 parts of Radix Morindae Officinaliss, 70 parts of Pericarpium Granatis, 40 parts of Semen Pharbitidiss, 50 parts of 35 parts of Herba Pyrolaes and Caulis Marsdeniae Tenacissimaes.
2. the medicine for the treatment of puerperal uterine contraction pain according to claim 1 is characterized in that described medicine can make tablet, dispersible tablet, decoction or powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310236037.XA CN103356980B (en) | 2013-06-17 | 2013-06-17 | Medicament for treating afterpains |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310236037.XA CN103356980B (en) | 2013-06-17 | 2013-06-17 | Medicament for treating afterpains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103356980A true CN103356980A (en) | 2013-10-23 |
| CN103356980B CN103356980B (en) | 2015-05-06 |
Family
ID=49359782
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310236037.XA Expired - Fee Related CN103356980B (en) | 2013-06-17 | 2013-06-17 | Medicament for treating afterpains |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103356980B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
| CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
| CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
| CN103285355A (en) * | 2013-06-14 | 2013-09-11 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN105287716A (en) * | 2015-11-26 | 2016-02-03 | 陈炳树 | Postpartum uterine contraction pain treating drug and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1195556A (en) * | 1997-04-08 | 1998-10-14 | 刘志恒 | Method for preparing medicinal liquor with heart and brain recovery function |
| CN1872275A (en) * | 2006-04-17 | 2006-12-06 | 韩贤哲 | Medication for treating diseases of orthopaedics, and preparation method |
-
2013
- 2013-06-17 CN CN201310236037.XA patent/CN103356980B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1195556A (en) * | 1997-04-08 | 1998-10-14 | 刘志恒 | Method for preparing medicinal liquor with heart and brain recovery function |
| CN1872275A (en) * | 2006-04-17 | 2006-12-06 | 韩贤哲 | Medication for treating diseases of orthopaedics, and preparation method |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103239700A (en) * | 2013-05-20 | 2013-08-14 | 黄慧 | Medicament for treating rheumatism |
| CN103251918A (en) * | 2013-06-03 | 2013-08-21 | 袁梅 | Medicine for treating gastrointestinal tract diseases |
| CN103251919A (en) * | 2013-06-03 | 2013-08-21 | 史秀华 | Medicine for treating upper respiratory tract infections |
| CN103285355A (en) * | 2013-06-14 | 2013-09-11 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN103285355B (en) * | 2013-06-14 | 2015-05-13 | 孟凡美 | Medicine for treating calculi in urinary system |
| CN105287716A (en) * | 2015-11-26 | 2016-02-03 | 陈炳树 | Postpartum uterine contraction pain treating drug and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103356980B (en) | 2015-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103356980B (en) | Medicament for treating afterpains | |
| CN103223155A (en) | Medicament for treating postpartum hemorrhage | |
| CN101780227B (en) | Traditional Chinese medicine composition for treating acute stroke and preparation method thereof | |
| CN104399050A (en) | Traditional Chinese medicine for treating postpartum hemorrhage | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN103285355B (en) | Medicine for treating calculi in urinary system | |
| CN102961719A (en) | Medicament for treating intravertebral postanesthesia shivering | |
| CN103550702A (en) | Traditional Chinese medicine composition for cerebral arterial thrombosis | |
| CN103893601B (en) | A kind of medicament for the treatment of mumps | |
| CN104922383A (en) | Composition capable of improving cardiovascular and cerebrovascular diseases and curing neck-shoulder pain | |
| CN104758530A (en) | Traditional Chinese medicine composition for treating deficiency of both qi and blood type irregular menstruation | |
| CN106309974A (en) | Traditional chinese medicine composition | |
| CN106421641A (en) | Traditional Chinese medicine composition and preparation for treating anorectal diseases | |
| CN102091304A (en) | Chinese medicine oral liquid with functions of restoring yang qi and dispelling cold and preparation method thereof | |
| CN104645173A (en) | Drug for treatment or adjuvant treatment of AIDS (Acquired Immune Deficiency Syndrome), and preparation method and use method thereof | |
| CN103432459A (en) | Pharmaceutical composition for treating acute upper respiratory infection | |
| CN103920017A (en) | Medicine composition for treating cervicitis | |
| CN109908274A (en) | A kind of expelling pathogenic factors from muscles and skin brings down a fever, clearing heat and detoxicating Chinese medicinal granular formulation | |
| CN103735781B (en) | A kind of medicament for the treatment of neurodermatitis | |
| CN103690675A (en) | Traditional Chinese medicine composition detoxicating pills with effects of clearing away heat and toxic materials and improving immunity | |
| CN103110735A (en) | Traditional Chinese medicine composition for treating dysmenorrheal and preparation method thereof | |
| CN103110924A (en) | Medicine for treating hemorrhoids | |
| CN103301261A (en) | Medicine for treating transplant kidney main renal venous stenosis | |
| CN102100860A (en) | Chinese medicine preparation used for treating mammitis | |
| CN102552503A (en) | Traditional Chinese medicine powder used for treating cervical erosion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150506 Termination date: 20160617 |